Hap Trading, LLC Alzamend Neuro, Inc. Call Options Transaction History

Hap Trading, LLC

  • $840 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.82 - $1.2 $16,564 - $24,240
-20,200 Reduced 34.3%
38,700 $1,000
Q1 2022

May 12, 2022
SELL
$0.91 - $2.23 $2,275 - $5,575
-2,500 Reduced 4.07%
58,900 $8,000
Q4 2021

Feb 14, 2022
BUY
$1.9 - $3.08 $82,840 - $134,288
43,600 Added 244.94%
61,400 $12,000
Q3 2021

Nov 10, 2021
BUY
$2.28 - $7.68 $40,584 - $136,704
17,800 New
17,800 $11,000

About Alzamend Neuro, Inc.

ALZN Quotes by TradingView
  • Ticker ALZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,481,800
  • Market Cap $158M
  • Description
  • Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...
More about ALZN
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email